Hot topic—News ｜ Bio@Taipei

News

CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate

2025.12.23

Dr. Hassan Al Ali’s Contribution to the Evolving Landscape of Drug Discovery

2025.12.18

Enterovirus Hits 6-Year Peak: 12,000 Weekly Cases Expose a Critical Void in Neonatal Diagnostics

2025.12.16

Precise Bio Achieves Historic First 3D-Bioprinted Corneal Implant In Human, Part Of Early Trial

2025.12.11

Next-Gen Sequencing Is Going Global, And 2026 Could Be the Tipping Point

2025.12.09

MIT’s Nerve-Regenerating Injectable Hydrogel: Breakthrough or Overhyped Miracle Shot?

2025.12.04

Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge

2025.12.02

Navigating Medtech Tariffs: Insights on Supply Chain Resilience, Cost Management, and Strategic Adaptation

2025.11.28

J&J MedTech bolsters stroke R&D programs in Ireland

2025.11.25

Japan’s Biotech Is Repositioning for Scale: JBA’s Tsukamoto on Capital, Capacity, and Cross-Border Models

2025.11.20

The Tiny Power Revolution Behind Consumer CGMs

2025.11.18

Celebrate a Century of VA Innovation by Collaborating on Your Next Medical Product

2025.11.13

Prosthetics: Firms Like Unhindr And Esper Shape Market On the Cusp of Great Change

2025.11.11

South Korea’s Celltrion Inks $744 Million Deal with U.S. Biotech, Eyeing Autoimmune Drug Market

2025.11.06

UK MHRA Deepens AI Regulatory Expertise As Airlock Moves Into Phase 2

2025.11.04

Total 21

Total 21

Back to top